BitMEX Co-Founder Arthur Hayes Invests in Stem Cell Longevity Company

Arthur Hayes has become a key investor and board member in a stem cell company with clinics in Mexico and Bangkok, highlighting a shift towards human longevity and healthspan extension.

Summary

Arthur Hayes, co-founder of BitMEX, has invested in a stem cell company with clinics in Mexico and Bangkok, joining its board. Hayes has been undergoing intravenous infusion treatments to extend his lifespan and emphasized the easing of global stem cell regulations. Hayes' family office, Maelstrom, has also invested in three digital asset vault companies, while he cautioned about the sector’s risks. More crypto executives are exploring longevity technologies alongside digital asset investments.

Terms & Concepts
  • Stem Cell Therapy: A medical treatment that uses stem cells to repair, regenerate, or replace damaged tissues or cells.
  • Longevity Investment: An investment strategy focused on companies and technologies that aim to extend human lifespan and improve health outcomes.
  • Intravenous Infusion: A method of delivering treatments directly into the bloodstream through a vein, often used in advanced therapies like stem cell treatments.